๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

292 Tegafox, a new combination of UFT/LV and oxaliplatin as first line treatment for patients (pts) with non resectable metastatic colorectal cancer (CRC): results of a completed multicenter phase II

โœ Scribed by J. Bennouna; H. Perrier; B. Paillot; J.H. Priou; J.H. Jacob; M. Hebbar; S. Bordenave; J.F. Seitz; D. Tonelli; J.Y. Douillard


Book ID
118620467
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
331 KB
Volume
1
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


6096 POSTER FOLFOXIRI (Irinotecan, Oxali